MarginsXMarginsX
Home › Markets › SMNR

Semnur Pharmaceuticals, Inc. (SMNR)

SMNR is quoted over the counter, not listed on an exchange. Semnur Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.4700
+42.4% on the day
1-year return
-94.8%
Market cap
$102.3M
Micro cap. From the Nov 13, 2026 close × 217.7M shares (10-Q cover page, Nov 4, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerSMNR, quoted over the counter
SEC CIK0001913577
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressPalo Alto, CA
Incorporated inDE

Warning signs

Cash runway
0.1 months
$54K cash at September 30, 2026
Share count, 1 year
-5.2%
2025-11-10 to 2026-11-04
Going-concern doubt
Yes
10-Q filed November 4, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are 7 issued."
10-Q 2026-11-04
Cash and burn$54K cash; operating cash flow -$2.7M a quarter.Report 2026-09-30
Shares outstanding217,709,142 (2026-11-04); 229,740,978 a year earlier.Cover page 2026-11-04
Reverse splits, 3 years1; latest on 2025-09-26Source 2025-09-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-07-14
AuditorPipara & Co LLP, New Delhi, India; changed auditors 1 time in 24 months8-K 4.01 2025-09-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$3.6M-$2.2M$54K$2.3MNeeds four quarters10-Q 2026-11-04
Q2 2026
2026-06-30
Not filed-$4.3M-$2.1M$39K$2.1MNeeds four quarters10-Q 2026-11-04
Q1 2026
2026-03-31
Not filed-$4.6M-$2.7M$103K$2.8MNeeds four quarters10-Q 2026-11-04
Q4 2025
2025-12-31
Not filed-$6.2M-$3.6M$20K$3.5MNeeds four quarters10-K 2026-02-27
Q3 2025
2025-09-30
Not filed-$152.6M-$2.1M$85K$4.5MNeeds four quarters10-Q 2026-11-04
Q2 2025
2025-06-30
Not filed-$999K$268K$55K$1.4MNeeds four quarters10-Q 2026-11-04
Q1 2025
2025-03-31
Not filed-$665K-$399K$7K$1.4MNeeds four quarters10-Q 2026-11-04
Q4 2024
2024-12-31
Not filed-$167K-$1.4M$12K$1.4MNeeds four quarters10-K 2025-04-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-07-07
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-07-07
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 221 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier